baby monitoring
Owlet360 will provide caregivers personalized insights into their infant's health, sleep patterns and development using the company's pediatric health data.
The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.
The company's Dream Sock, which received FDA 510(k) clearance in November, gathers real-time health readings, including a baby's sleep trends and pulse rate.
BabySat, available via prescription, alerts parents when their baby's heart rate or blood oxygen saturation falls out of a prescribed range.
The company currently sells connected wearables and smart monitors to consumers, but said that it will be seeking FDA authorization for new products with broader indications and telehealth capabilities down the line.